Center “Vector”: “EpiVacCorona” vaccine is effective against three strains of COVID-19
After vaccination with EpiVacCorona, antibodies are produced that neutralize the classic, British and South African strains of the coronavirus. This was reported to TASS in the Center for Virology and Biotechnology “Vector” Rospotrebnadzor, the developer of the vaccine.
“As part of an experimental test of the effectiveness of the EpiVacCorona vaccine against the reference strain of the new coronavirus, as well as the British and South African variants, it was found that the antibodies induced by the vaccine have neutralizing activity against all of these strains,” the report said. Vektor also noted the effectiveness and safety of the drug, referring to the results of observation of participants in clinical trials of the first and second phases, as well as post-registration trials, including people over 60 years old.
EpiVacCorona is the second COVID-19 vaccine registered in Russia. This happened on October 14, 2020. Approximately a month later, permission was obtained to conduct post-registration studies, including among the elderly.
